Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The orbitofrontal cortex and beyond: from affect to decision-making
Weight loss, regardless of the method, can influence bone density through multiple physiological mechanisms
and 10:59 p.m
May support evaluation Common Eligibility Factors BMI of 30 or greater BMI of 27 or greater with a related health condition Prior lifestyle efforts without durable results Ability to attend monitoring and report symptoms Willingness to support nutrition, movement, and maintenance Needs more review Reasons to Avoid, Delay, or Modify Treatment Pregnancy, planned pregnancy, or breastfeeding Personal or family history of medullary thyroid carcinoma or MEN2 for Wegovy/Zepbound Severe gastroparesis or significant gastrointestinal disease Active or unstable eating disorder Prior serious allergy to the medicine Inability to maintain fluid or nutrition Medication interactions or uncontrolled illness These medicines are not intended for cosmetic weight loss The goal is treatment of obesity or clinically significant overweight-related risknot rapid loss of a few pounds for an event
For example, patients with higher BMI may experience greater weight loss and metabolic improvements
Li et al., Shape design of high drug payload nanoparticles for more effective cancer therapy
